An individual participant data meta-analysis clarifies which elements of collaborative care most effectively reduce depressive symptoms in primary care, informing implementation strategies for clinicians...
April 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...
A randomized clinical trial in Pakistan evaluated whether structured, measurement-based care could accelerate antidepressant response and remission in adults with major depressive disorder compared with...
The FDA has approved a supplemental indication for lumateperone to reduce relapse risk in adults with schizophrenia based on phase 3 randomized withdrawal data.
In two pragmatic randomized trials conducted in the Capital Region of Denmark, investigators compared collaborative care with consultation liaison in general practice to assess whether greater involvement...
A multinational cross-sectional survey of children and adolescents with moderate-to-severe atopic dermatitis found substantial disease burden, with distinct physical and psychosocial impacts by age group.
...
A large Finnish cohort study published in Neurology found that preinjury use of serotonergic antidepressants was not associated with increased 30-day mortality, emergency neurosurgical interventions, or...
A randomized clinical trial found that a 12-week web-based guided self-help program was noninferior to standard cognitive-behavioral therapy for reducing binge-eating episodes in adults with binge-eating...
Recent research found that soft drink consumption may be linked to major depressive disorder diagnosis and increased depressive symptom severity, with significant associations observed only among women.
...
A 3-year randomized trial found that older adults with untreated hearing loss who received a best-practice hearing intervention retained more diverse and robust social networks and reported less loneliness...
